Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Age-Related Macular Degeneration Occurs Earlier Than Presumed

By HospiMedica International staff writers
Posted on 04 Aug 2014
A new study to determine the incidence of age-related macular degeneration (AMD) shows that even those under the age of 50 can be affected by an early form of the disease.

Researchers at Johannes Gutenberg University (JGU; Mainz, Germany) evaluated fundus photographs of 4,340 subject (35–74 years of age) participating in the Gutenberg Health Study (GHS), a single-center study in the Rhineland-Palatine region of Germany. More...
Fundus images were evaluate and classified by vascular structure, the head of the optic nerve, and the macula of the eye. They were also graded independently by two experienced ophthalmologists, based on the presence of hard and soft drusen, retinal pigmentary abnormalities, and signs of atrophic or neovascular AMD.

The results revealed that the incidence of AMD increases with age, and that even persons under the age of 50 years could already be affected by early stage AMD; in the age group of 35- to 44-year-olds, 3.8% of the subjects were found to be suffering from the disease. On average, about 12% of all participants had early stage AMD, but only 0.2% exhibited symptoms of late stage AMD, which is often associated with severe visual impairment. The study was published ahead of print on February 25, 2014, in Graefe's Archive for Clinical and Experimental Ophthalmology.

“Our research shows that age-related macular degeneration can already occur much earlier than previously thought. This means there may also be possible consequences with regard to the screening examinations for these diseases,” concluded lead author Christina Korb, MD, and colleagues. “The findings thus contradict the current assumption that AMD only occurs in the section of the population that is over 50 years old.”

AMD is a medical condition that is a major cause of blindness and visual impairment in older adults due to damage to the retina in the center of the visual field (the macula). AMD, which occurs in dry and wet forms, make it difficult or impossible to read or recognize faces, although enough peripheral vision remains to allow other activities of daily life. In the dry (nonexudative) form, cellular debris called drusen accumulates between the retina and the choroid, and the retina can become detached. In the more severe, wet (exudative) form, blood vessels grow from the choroid behind the retina, and the retina can also become detached.

Related Links:

Johannes Gutenberg University Mainz



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.